This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Bipolar Disorder  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We appreciate the thoughtful questions from Drs Williams and Adetunji. As they indicate in their letter concerning our study, there has been an inconsistency between remission results as presented at the 2003 American Psychiatric Association Annual Meeting and in the published article. In this letter, we clarify this inconsistency.

As described in the study protocol, remission results were prepared based on patients who had completed 4 weeks of acute-phase therapy. The poster presentation at the 2003 American Psychiatric Association Annual Meeting provided these remission results, as did the original draft manuscript. As part of the scientific peer-review process at the ARCHIVES, a request was made for the article to alternatively provide remission results for all randomized patients to be consistent with the intent-to-treat-principle and with a definition used by other investigators. The article was revised to comply with the reviewer’s comment. Thus, the published article contains . . . [Full Text of this Article]

AUTHOR INFORMATION
Mauricio Tohen, MD, DrPH; Rick Risser, MS

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Olanzapine and Olanzapine-Fluoxetine Combination Treatment and Bipolar I Depression
A. B. Williams and B. A. Adetunji
Arch Gen Psychiatry. 2005;62(9):1052.
EXTRACT | FULL TEXT